Michael D. Raleigh

752 total citations
24 papers, 601 citations indexed

About

Michael D. Raleigh is a scholar working on Toxicology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Michael D. Raleigh has authored 24 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Toxicology, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Molecular Biology. Recurrent topics in Michael D. Raleigh's work include Forensic Toxicology and Drug Analysis (11 papers), Opioid Use Disorder Treatment (11 papers) and Pain Mechanisms and Treatments (7 papers). Michael D. Raleigh is often cited by papers focused on Forensic Toxicology and Drug Analysis (11 papers), Opioid Use Disorder Treatment (11 papers) and Pain Mechanisms and Treatments (7 papers). Michael D. Raleigh collaborates with scholars based in United States, United Kingdom and Italy. Michael D. Raleigh's co-authors include Paul R. Pentel, Marco Pravetoni, Angela K. Birnbaum, Mark LeSage, Federico Baruffaldi, Theresa Harmon, Morgan Le Naour, Andrew C. Harris, Chenming Zhang and Zongmin Zhao and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Biomaterials.

In The Last Decade

Michael D. Raleigh

23 papers receiving 590 citations

Peers

Michael D. Raleigh
Theresa Harmon United States
Federico Baruffaldi United States
Candy S. Hwang United States
Megan Laudenbach United States
Morgan Le Naour United States
Ashli M. Tucker United States
Jordan Trecki United States
Laureen J. Marinetti United States
Nina Lindblom Sweden
Hélène Marty France
Theresa Harmon United States
Michael D. Raleigh
Citations per year, relative to Michael D. Raleigh Michael D. Raleigh (= 1×) peers Theresa Harmon

Countries citing papers authored by Michael D. Raleigh

Since Specialization
Citations

This map shows the geographic impact of Michael D. Raleigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Raleigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Raleigh more than expected).

Fields of papers citing papers by Michael D. Raleigh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Raleigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Raleigh. The network helps show where Michael D. Raleigh may publish in the future.

Co-authorship network of co-authors of Michael D. Raleigh

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Raleigh. A scholar is included among the top collaborators of Michael D. Raleigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Raleigh. Michael D. Raleigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Averick, Saadyah, et al.. (2024). Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP. Frontiers in Psychiatry. 15. 1366186–1366186. 5 indexed citations
3.
Baehr, Carly, et al.. (2024). Monoclonal Antibodies Engineered with Fc Region Mutations to Extend Protection against Fentanyl Toxicity. The Journal of Immunology. 213(5). 663–668. 4 indexed citations
4.
Marker, Cheryl L., et al.. (2022). Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder. Vaccine. 40(23). 3244–3252. 11 indexed citations
5.
Raleigh, Michael D., Nicola Beltraminelli, Mark LeSage, et al.. (2021). Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies. PLoS ONE. 16(7). e0254247–e0254247. 5 indexed citations
6.
Raleigh, Michael D., Samantha J. King, Federico Baruffaldi, et al.. (2021). Pharmacological mechanisms underlying the efficacy of antibodies generated by a vaccine to treat oxycodone use disorder. Neuropharmacology. 195. 108653–108653. 14 indexed citations
7.
Kassick, Andrew J., Nestor Tomycz, Toby L. Nelson, et al.. (2021). Covalently Loaded Naloxone Nanoparticles as a Long-Acting Medical Countermeasure to Opioid Poisoning. ACS Pharmacology & Translational Science. 4(5). 1654–1664. 16 indexed citations
8.
Raleigh, Michael D., et al.. (2020). Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity. Journal of Pharmacology and Experimental Therapeutics. 374(3). 392–403. 12 indexed citations
9.
Baruffaldi, Federico, Michael D. Raleigh, Samantha J. King, et al.. (2019). Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation. Molecular Pharmaceutics. 16(6). 2364–2375. 13 indexed citations
10.
Pentel, Paul R., Michael D. Raleigh, Mark LeSage, et al.. (2018). The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats. BMC Biotechnology. 18(1). 46–46. 13 indexed citations
11.
Raleigh, Michael D., Federico Baruffaldi, Morgan Le Naour, et al.. (2018). A Fentanyl Vaccine Alters Fentanyl Distribution and Protects against Fentanyl-Induced Effects in Mice and Rats. Journal of Pharmacology and Experimental Therapeutics. 368(2). 282–291. 71 indexed citations
12.
Raleigh, Michael D., Megan Laudenbach, Federico Baruffaldi, et al.. (2018). Opioid Dose- and Route-Dependent Efficacy of Oxycodone and Heroin Vaccines in Rats. Journal of Pharmacology and Experimental Therapeutics. 365(2). 346–353. 43 indexed citations
13.
14.
Raleigh, Michael D., Megan Laudenbach, Federico Baruffaldi, et al.. (2017). Safety and efficacy of an oxycodone vaccine: Addressing some of the unique considerations posed by opioid abuse. PLoS ONE. 12(12). e0184876–e0184876. 71 indexed citations
15.
Zhao, Zongmin, et al.. (2016). A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy. Nanomedicine Nanotechnology Biology and Medicine. 13(2). 443–454. 42 indexed citations
16.
Raleigh, Michael D., Paul R. Pentel, & Mark LeSage. (2014). Pharmacokinetic Correlates of the Effects of a Heroin Vaccine on Heroin Self-Administration in Rats. PLoS ONE. 9(12). e115696–e115696. 43 indexed citations
17.
Pravetoni, Marco, Michael D. Raleigh, Morgan Le Naour, et al.. (2012). Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats. Vaccine. 30(31). 4617–4624. 72 indexed citations
18.
Raleigh, Michael D., Marco Pravetoni, Andrew C. Harris, Angela K. Birnbaum, & Paul R. Pentel. (2012). Selective Effects of a Morphine Conjugate Vaccine on Heroin and Metabolite Distribution and Heroin-Induced Behaviors in Rats. Journal of Pharmacology and Experimental Therapeutics. 344(2). 397–406. 62 indexed citations
19.
Jones, Jessica, Michael D. Raleigh, Paul R. Pentel, et al.. (2012). Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC–MS assay for delayed analyses of pharmacokinetic samples in rats. Journal of Pharmaceutical and Biomedical Analysis. 74. 291–297. 29 indexed citations
20.
Pravetoni, Marco, Daniel E. Keyler, Michael D. Raleigh, et al.. (2011). Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats. Biochemical Pharmacology. 81(9). 1164–1170. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa Harmon Breakdown of academic impact, for papers by Federico Baruffaldi Breakdown of academic impact, for papers by Candy S. Hwang Breakdown of academic impact, for papers by Megan Laudenbach Breakdown of academic impact, for papers by Morgan Le Naour Breakdown of academic impact, for papers by Ashli M. Tucker Breakdown of academic impact, for papers by Jordan Trecki Breakdown of academic impact, for papers by Laureen J. Marinetti Breakdown of academic impact, for papers by Nina Lindblom Breakdown of academic impact, for papers by Hélène Marty
Rankless by CCL
2026